Tatsushi Shimokuni

Aberrant Methylation of <b> <i>DPYD</i> </b> Promoter, <b> <i>DPYD</i> </b> Expression, and Cellular Sensitivity to 5-Fluorouracil in Cancer Cells

Takuya Noguchi, Keiji Tanimoto, Tatsushi Shimokuni et al. · Clinical Cancer Research · 2004 · 58 citations

Human carboxylesterase 1A2 expressed from carboxylesterase 1A1 and 1A2 genes is a potent predictor of CPT-11 cytotoxicity in vitro

Keiji Tanimoto, Mika Kaneyasu, Tatsushi Shimokuni et al. · Pharmacogenetics and Genomics · 2007 · 40 citations

Selection of a novel drug-response predictor in esophageal cancer: A novel screening method using microarray and identification of IFITM1 as a potent marker gene of CDDP response

Shoichi Fumoto, Tatsushi Shimokuni, Keiji Tanimoto et al. · International Journal of Oncology · 2008 · 33 citations · Full text

Engineering, Esophageal Cancer, Immunology +17

Activator Protein Accelerates Dihydropyrimidine Dehydrogenase Gene Transcription in Cancer Cells

Kei Ukon, Keiji Tanimoto, Tatsushi Shimokuni et al. · Cancer Research · 2005 · 19 citations · Full text

Molecular Biology, Cancer Biology, Tumor Biology +17

Chemosensitivity prediction in esophageal squamous cell carcinoma: Novel marker genes and efficacy-prediction formulae using their expression data

Tatsushi Shimokuni, Keiji Tanimoto, Keiko Hiyama et al. · International Journal of Oncology · 2006 · 18 citations · Full text

Esophageal Cancer, Chemosensitivity Prediction, Expression Data +12